Investor Relations

Syneron Medical Ltd (ELOS) IR Room

Press Releases

These are news releases that are related to our Investor efforts.  Releases are listed in chronological order and are archived by year.  Sign-up to receive news as it is released using the email and RSS tools below.

Archives: Search / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2010 / 2009 / 2008 / 2007 / 2006 / 2005 / 2004

2012 Archives

The new Sublative iD™ Focal Tip ensures Company’s commitment to elōs Plus™, eTwo™ and eMatrix™ customers by expanding treatment options for their patients.
Revenue of $60.1 million, up 6% Year-Over-Year
Syneron management will host a conference call and a live webcast at 8:30 a.m. (ET) on the same day. A question & answer session will follow management's discussion of events in the third quarter 2012.
First and only FDA cleared home-use hair removal device approved for all skin tones
Appoints SCDistribution Laser to sell and market LiteTouch™ in France
New Gentle Pro-U Series Allows Customers to Upgrade Systems to Dual Wavelength Configurations for Enhanced Performance and Additional Clinical Indications
- New survey reveals more than 90 per cent of women say there is something about their body they would change1 -
Partners with LH Medical GmbH, a leading medical device distributor in Germany
Current Board Member and Former CEO/CFO David Schlachet to Serve as Interim CFO; Executive Search for Permanent Replacement Initiated
All time high revenue of $68.1 million, up 12% Year-Over-Year
UltraShape® business to be supported by Syneron's direct sales, service and customer support services headquartered in Toronto, Canada
Offers up to eight in-demand treatment options with higher performance in a compact upgradable system
Price Data

print email rss